No Data
No Data
Emerging market outlook: Will the Growth Market 250 Index take a break and individual stock picking strengthen with positive investor sentiment?
■ The emerging market this week has seen a significant increase in overall market conditions, with major stocks showing strength. During the same period, while the Nikkei Average increased by +0.79%, the Growth Market Index rose by +4.63% and the Growth Market 250 Index rose by +5.16%, highlighting the growth of the emerging market. Similar to the main board, trading volume has not expanded significantly, but driven by improved investor sentiment, major stocks with large market capitalization, such as constituents of the Growth Market Core Index, have shown overall strength. The Growth Market 250 Index opened on August 1st.
Anges - Significant revenue growth in the second quarter, with commodity revenue recorded due to sales of the early aging drug "Zokinvi".
On the 9th, ANGELS <4563> announced its consolidated financial results for the second quarter of the fiscal year ending December 2024 (January to June 24). Revenue increased 578.5% from the same period last year to 0.347 billion yen, operating loss was 5.107 billion yen (compared to a loss of 5.951 billion yen in the same period last year), ordinary loss was 3.19 billion yen (compared to a loss of 4.776 billion yen in the same period last year), and intermediate net loss attributable to parent company shareholders was 3.5 billion yen (compared to a loss of 4.83 billion yen in the same period last year). Business revenue during this interim accounting period continued to show significant growth.
AnGes: Confirmation letter
AnGes: Semi-annual report - 26th period (01/01/2024-12/31/2024)
AnGes-Records non-operating income, non-operating expenses, special profit, special loss and adjusted amount of corporate tax.
On the 9th, Anges <4563> announced the inclusion of non-operating income, non-operating expenses, special profits, special losses, and adjustments for corporate taxes, etc. during the interim consolidated accounting period for the year ending December 2024 (January-June 2024). Non-operating income includes exchange gains of 1.916 billion yen and subsidies of 0.027 billion yen. Non-operating expenses include stock issuance expenses of 0.03 billion yen. Special profit includes subscription rights return income of 0.003 billion yen. Special loss includes business restructuring expenses of 0.23 billion yen.
AnGes: 2nd quarter (interim period) financial results for December 2024, based on Japanese accounting standards (consolidated).
No Data